You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復旦張江(01349.HK)首季轉虧蝕1,828萬人幣 料上半年業績續受疫情影響
阿思達克 05-18 08:59
復旦張江(01349.HK)公布,自疫情爆發以來,藥品流通及醫院患者就診受阻,今年首季營業收入較2019年同期下降58.45%至3,471.67萬元人民幣(下同),季內錄淨虧損1,828.61萬元,去年同期純利為490.25萬元。

由於目前仍處於疫情管控期間,各地醫院及附屬科室仍處於陸續開放過程中,前往醫院就診的患者數量及就診頻率仍明顯低於正常水準。受患者就醫環境的整體影響,集團今年上半年經營業績仍將受到較大影響。經公司初步測算,預計上半年營業收入約為1.77億元至2.53億元,按年減少35%至55%;錄得淨利潤約為1,882萬元至淨虧損2,497萬元,2019年同期純利為9,171.96萬元。

公司補充,預測疫情對藥品銷售的影響在下半年將基本消除;此外針對疫情影響,公司今年已加大學術推廣及市場開拓力度,預計下半年集團藥品銷售收入有望達到去年同期水準。綜上所述,公司初步預計,今年全年營業收入約為7.8億元至9億元之間,按年下降13%至24%;淨利潤約為1.2億元至1.8億元之間,按年下降21%至47%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account